Dallas, TX, February 09, 2017 --(PR.com
)-- The global coronary stents market is expected to reach USD 6.4 billion by 2024 from USD 5.3 billion in 2016, at a CAGR of 2.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The global coronary stents market is segmented on the basis of product type, usability, end-user, distribution channel and geography.
On the basis of product type the coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent. The DES is further segmented into biodegradable and non-biodegradable.
Based on drugs the market is further segmented into paclitaxel, and limus-based drugs.
On the basis of application the market is further segmented into coronary artery disease, and peripheral artery disease.
Based on end-user, the market is segmented into hospitals, and cardiac centres.
Request for sample pages: http://databridgemarketresearch.com/reports/coronary-stents-market-trends-forecast-2024/
Based on geography the market is segmented into North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The report of this market shares covers data for countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. The report includes company share data for different geographies including Global, North America, Europe and APAC.
Read more: http://databridgemarketresearch.com/coronary-stents-market-poised-grow-2-4/
The key players operating in this market are Abbott Vascular, SciTech, Boston Scientific Corporation, Minvasys, Medinol Ltd, iVascular SLU, Elixir Medical Corporation, Inspire MD, Stentys SA,Hexacath, Medtronic, Andramed GmbH, Cordis Corporation, Orbusneich, Eurocor GmbH, Comed B.V., Endocor GmbH, MicroPort Scientific Corporation, Amaranth Medical, Inc., Terumo Corporation, Degania Silicone Ltd., Meril Life Sciences Pvt. Ltd., InSitu Technologies Inc., Alvimedica, Biotronik SE & Co. KG, Elixir Medical Corporation, AMG International GmbH, Arthesys, Lepu Medical, Translumina GmbH, Accura, Svelte Medical, B. Braun Melsungen AG and, Eucatech AG among others.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.